Risk-Based Validation Approach for New Stability Chambers
As pharmaceutical companies expand or modernize their stability testing infrastructure, the need to validate new stability chambers becomes inevitable. Traditionally, validation followed a one-size-fits-all model, but today’s regulatory bodies encourage a risk-based validation (RBV) approach—especially for equipment qualification. This tutorial outlines how to implement a compliant, efficient RBV framework for new chambers. What is Risk-Based…
Read More “Risk-Based Validation Approach for New Stability Chambers” »